Leszek Lisowski, PhD, MBA

Children's Medical Research Institute, University of Sydney, Associate Professor


What is your current professional status?

Group Leader, Associate Professor

What is your work setting?

Academic Institution

What is your scientific area of research?

Vector based gene therapy and genome editing.

Why do you want to be a mentor?

Science/research is a hard and demanding career and from my personal experience, a good mentor makes all the difference. Mentor doesn't have to be the direct PhD or postdoctoral supervisor, but anyone who went through similar path and can share his/her experiences. Somebody who can listen to our problems and who can understand us, because of going through similar experiences in the past. I hope to be able to share my experiences and lessons learned with the next generation of researchers. Maybe I will make somebody's life just a little bit easier and will contribute to improve his/her career and life in general

As a mentor, what are you hoping to gain from this experience?

I am still learning. I hope to learn from the people i mentor, just as much as I hope they will learn from me. Also, this is a great way to meet new people and expand my professional network.

How important are the following in the selection of a mentee?
(1 – 5 scale, 1 = most important, 5 = least important)

Compatibility of Scientific Specialties: 4

Geographic Location: 4

Professional Status / Success: 2

Compatibility of Career Path: 3

Communication Style: 1 (most)

Summarize in a brief paragraph (150 words or less), please provide a biography that describes who you are and what you do in the field of gene and/or cell therapy.

I was born in Poland and relocated to the US to undertake my undergraduate education. I continued on to obtain my PhD in Molecular Biology and Genetics from Cornell University/Memorial Sloan Kettering, NY. I subsequently undertook a full-time post-doctoral position at Stanford University where I trained under Prof Mark Kay in recombinant adeno-associated virus (rAAV) technologies.

In 2013 I was recruited by the Salk Institute for Biological Studies to head the Gene Transfer, Targeting and Therapeutics Facility, following which he was recruited by Children's Medical Research Institute to establish and direct the Vector and Genome Engineering Facility (VGEF) and to establish an independent Translational Vectorology Research Group (TVG).

My research focuses on AAV biology, AAV-mediated gene transfer and gene editing, including development of AAV technology platforms for selection and manufacturing of novel AAV variants for gene therapy targeting the eye, central nervous system and liver.

View CV

2019
22nd Annual Meeting
April 29 – May 2 | Washington D.C.
Close